Skip to main content
. 2022 Jun 27;11(11):e024214. doi: 10.1161/JAHA.121.024214

Figure 1. Patient selection flow chart.

Figure 1

From July 28, 2011, to December 30, 2016, the enrollment period of EAST‐AFNET 4 (Early Treatment of Atrial Fibrillation for Stroke Prevention Trial), we identified 109 739 patients with newly diagnosed atrial fibrillation (AF) (overall cohort). The majority of patients (72.9%; 79 948 of 109 739) would have been eligible for EAST‐AFNET 4. AAD indicates antiarrhythmic drug.